As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York, according to Infection Control Today.
“Approximately three years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on anti-fungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
Cathryn Jakicic is healthcare industries editor of FacilitiesNet.com. For more information on hospital campuses and other medical facilities, check out the FacilitiesNet healthcare page.
